• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化型甲状腺癌伴甲状腺外侵犯手术范围的当代趋势

Contemporary trends in extent of surgery for differentiated thyroid cancer with extrathyroidal extension.

作者信息

Montgomery Kelsey B, Fazendin Jessica M, Chen Herbert, Broman Kristy K

机构信息

Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.

Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.

出版信息

Am J Surg. 2024 Feb;228:173-179. doi: 10.1016/j.amjsurg.2023.09.021. Epub 2023 Sep 15.

DOI:10.1016/j.amjsurg.2023.09.021
PMID:37722937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10922190/
Abstract

OBJECTIVE

Although lobectomy is acceptable for patients with small, low-risk differentiated thyroid cancer (DTC), gross extrathyroidal extension (ETE) remains an indication for total thyroidectomy (TT). Here we investigate evolving trends in extent of surgery for ​+ ​ETE DTC.

METHODS

Patients with +ETE DTC who underwent resection from 2010 to 2020 were identified using the National Cancer Database. The primary outcome was performance of TT versus lobectomy.

RESULTS

Among 5851 patients, most were female (79.7%), white (80.0%), and had minimal ETE (91.8%). Ninety-two percent of patients received TT. Year of treatment was influential (p ​< ​0.001), with increasing lobectomy rates in later years. On multivariable analyses, a decreased likelihood of TT was seen in years 2015 through 2020.

CONCLUSIONS

Most patients with +ETE DTC underwent guideline-concordant TT, but lobectomy rates doubled over the study period. These findings may reflect increased preference for lobectomy in low-risk DTC, but could undertreat patients with high-risk features.

摘要

目的

虽然对于小型、低风险分化型甲状腺癌(DTC)患者,肺叶切除术是可以接受的,但肉眼可见的甲状腺外侵犯(ETE)仍然是全甲状腺切除术(TT)的指征。在此,我们研究了伴有ETE的DTC手术范围的演变趋势。

方法

利用国家癌症数据库识别出2010年至2020年期间接受切除术的伴有ETE的DTC患者。主要结局是TT与肺叶切除术的实施情况。

结果

在5851例患者中,大多数为女性(79.7%)、白人(80.0%),且ETE程度较轻(91.8%)。92%的患者接受了TT。治疗年份有影响(p<0.001),后期肺叶切除术率增加。在多变量分析中,2015年至2020年期间TT的可能性降低。

结论

大多数伴有ETE的DTC患者接受了符合指南的TT,但在研究期间肺叶切除术率翻了一番。这些发现可能反映出在低风险DTC中对肺叶切除术的偏好增加,但可能会对具有高风险特征的患者治疗不足。

相似文献

1
Contemporary trends in extent of surgery for differentiated thyroid cancer with extrathyroidal extension.分化型甲状腺癌伴甲状腺外侵犯手术范围的当代趋势
Am J Surg. 2024 Feb;228:173-179. doi: 10.1016/j.amjsurg.2023.09.021. Epub 2023 Sep 15.
2
Unilateral Multifocality Is Not a Risk Factor for Recurrence After Thyroid Lobectomy: A Study of 1,684 Patients With Differentiated Thyroid Cancer.单侧多灶性不是甲状腺叶切除术后复发的危险因素:一项 1684 例分化型甲状腺癌患者的研究。
In Vivo. 2023 Jul-Aug;37(4):1802-1808. doi: 10.21873/invivo.13270.
3
Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk?分化型甲状腺癌患儿的风险分层:任何风险患者都需要行甲状腺全切除术吗?
Thyroid. 2020 Apr;30(4):548-556. doi: 10.1089/thy.2019.0231. Epub 2020 Mar 11.
4
Analysis of risk factors and prognosis in differentiated thyroid cancer with focus on minimal extrathyroidal extension.分析分化型甲状腺癌的危险因素和预后,重点关注微小甲状腺外侵犯。
BMC Endocr Disord. 2021 Aug 10;21(1):161. doi: 10.1186/s12902-021-00826-2.
5
Total thyroidectomy or thyroid lobectomy in patients with low-risk differentiated thyroid cancer: surgical decision analysis of a controversy using a mathematical model.低危分化型甲状腺癌患者的全甲状腺切除术或甲状腺叶切除术:使用数学模型对一个争议问题的手术决策分析
World J Surg. 2000 Nov;24(11):1295-302. doi: 10.1007/s002680010215.
6
Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis.全甲状腺切除术与叶切除术治疗中危甲状腺乳头状癌:单机构配对分析。
Oral Oncol. 2019 Mar;90:17-22. doi: 10.1016/j.oraloncology.2019.01.010. Epub 2019 Jan 31.
7
Frequency of High-Risk Characteristics Requiring Total Thyroidectomy for 1-4 cm Well-Differentiated Thyroid Cancer.1-4厘米分化型甲状腺癌需行全甲状腺切除术的高危特征发生率
Thyroid. 2016 Jun;26(6):820-4. doi: 10.1089/thy.2015.0495. Epub 2016 May 20.
8
Individualizing Surgery in Papillary Thyroid Carcinoma Based on a Detailed Sonographic Assessment of Extrathyroidal Extension.基于甲状腺外侵犯的详细超声评估对甲状腺乳头状癌进行个体化手术。
Thyroid. 2017 Dec;27(12):1544-1549. doi: 10.1089/thy.2017.0457.
9
Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.同质管理的pT3分化型甲状腺癌人群中的复发风险。
Langenbecks Arch Surg. 2018 May;403(3):325-332. doi: 10.1007/s00423-018-1657-2. Epub 2018 Feb 14.
10
Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.根据甲状腺切除术的范围,1 至 4 厘米分化型甲状腺癌患者的肿瘤学结果。
Head Neck. 2019 Jan;41(1):56-63. doi: 10.1002/hed.25356. Epub 2018 Dec 10.

引用本文的文献

1
Coagulation and thyroiditis are factors associated with adverse pathological features in differentiated thyroid cancer: a retrospective cohort study.凝血与甲状腺炎是分化型甲状腺癌不良病理特征的相关因素:一项回顾性队列研究。
BMC Surg. 2025 Apr 11;25(1):150. doi: 10.1186/s12893-025-02898-6.
2
Patterns of Referral for Common Cancer Surgery in the United States.美国常见癌症手术的转诊模式。
Ann Surg Oncol. 2025 May;32(5):3429-3440. doi: 10.1245/s10434-025-17026-0. Epub 2025 Feb 18.
3
Comparing therapeutic outcomes: radioactive iodine therapy versus non-radioactive iodine therapy in differentiated thyroid cancer.比较治疗效果:分化型甲状腺癌的放射性碘治疗与非放射性碘治疗。
Front Endocrinol (Lausanne). 2024 Sep 20;15:1442714. doi: 10.3389/fendo.2024.1442714. eCollection 2024.
4
The overtreatment of papillary thyroid microcarcinoma in the community.社区中甲状腺微小乳头状癌的过度治疗。
Am J Surg. 2024 Jul;233:132-135. doi: 10.1016/j.amjsurg.2024.03.004. Epub 2024 Mar 4.

本文引用的文献

1
Quality indicators for thyroid cancer care: What should surgeons know?甲状腺癌治疗的质量指标:外科医生应该知道什么?
Am J Surg. 2023 Jun;225(6):1108-1110. doi: 10.1016/j.amjsurg.2023.02.007. Epub 2023 Feb 10.
2
External beam radiotherapy for thyroid cancer: Patients, complications, and survival.甲状腺癌的外照射治疗:患者、并发症和生存。
Am J Surg. 2023 Jun;225(6):994-999. doi: 10.1016/j.amjsurg.2023.01.009. Epub 2023 Jan 11.
3
Synoptic operative reporting in cancer surgery: A scoping review.癌症手术中的概要手术报告:范围综述。
Am J Surg. 2023 May;225(5):878-886. doi: 10.1016/j.amjsurg.2023.01.003. Epub 2023 Jan 7.
4
Racial/ethnic disparities in thyroid cancer in California, 1999-2017.加利福尼亚州 1999-2017 年甲状腺癌的种族/民族差异。
Am J Surg. 2023 Feb;225(2):298-303. doi: 10.1016/j.amjsurg.2022.09.041. Epub 2022 Sep 24.
5
There's no such thing as a free lunch: Outcomes of concurrent parathyroidectomy and thyroidectomy among CESQIP surgeons.天下没有免费的午餐:CESQIP外科医生同期甲状旁腺切除术和甲状腺切除术的结果
Am J Surg. 2022 Nov;224(5):1188-1189. doi: 10.1016/j.amjsurg.2022.05.025. Epub 2022 May 25.
6
Outcomes of concurrent parathyroidectomy and thyroidectomy among CESQIP surgeons.CESQIP 外科医生同期甲状旁腺切除术和甲状腺切除术的结果。
Am J Surg. 2022 Nov;224(5):1190-1196. doi: 10.1016/j.amjsurg.2022.03.041. Epub 2022 Mar 26.
7
Association of Total Thyroidectomy or Thyroid Lobectomy With the Quality of Life in Patients With Differentiated Thyroid Cancer With Low to Intermediate Risk of Recurrence.全甲状腺切除术或甲状腺叶切除术与低至中度复发风险分化型甲状腺癌患者生活质量的关系。
JAMA Surg. 2022 Mar 1;157(3):200-209. doi: 10.1001/jamasurg.2021.6442.
8
Does macroscopic extrathyroidal extension to the strap muscles alone affect survival in papillary thyroid carcinoma?单纯带状肌外甲状腺外侵犯对甲状腺乳头状癌的生存是否有影响?
Surgery. 2022 May;171(5):1341-1347. doi: 10.1016/j.surg.2021.08.041. Epub 2021 Sep 30.
9
Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.半甲状腺切除术治疗微小甲状腺外侵犯的甲状腺乳头状癌的疗效。
Eur Arch Otorhinolaryngol. 2019 Dec;276(12):3435-3442. doi: 10.1007/s00405-019-05598-z. Epub 2019 Aug 14.
10
The 2015 American Thyroid Association guidelines are associated with an increasing rate of hemithyroidectomy for thyroid cancer.2015 年美国甲状腺协会指南与甲状腺癌患者行甲状腺腺叶切除术的比例增加有关。
Surgery. 2019 Sep;166(3):349-355. doi: 10.1016/j.surg.2019.03.002. Epub 2019 May 2.